When Getting Lean Raises Your Cholesterol: The LMHR Effect Explained
Some of the leanest, healthiest people on keto see their LDL skyrocket. The Lean Mass Hyper-Responder phenotype explains why — and what it actually means for heart health.
Some lean, metabolically healthy people on keto see dramatic LDL increases — often over 200 mg/dL — alongside high HDL and low triglycerides. This is called the Lean Mass Hyper-Responder (LMHR) phenotype. Early evidence suggests it may reflect increased lipid trafficking for energy rather than increased cardiovascular risk, but long-term data is still limited. If this is you, understanding the pattern helps you have a more informed conversation with your doctor.
You’re lean. You exercise. You eat clean keto or carnivore. You feel great.
Then you get your blood work back and your LDL cholesterol is 250 mg/dL.
Your doctor’s eyes go wide. You get the statin speech. And you’re left wondering: how can someone in the best shape of their life have cholesterol numbers that look like a cardiovascular time bomb?
Welcome to the world of the Lean Mass Hyper-Responder.
What Is a Lean Mass Hyper-Responder?
The term was coined by citizen scientist Dave Feldman, who noticed a striking pattern while collecting lipid data from thousands of people on low-carb diets. A specific subset — the leanest, most metabolically healthy individuals — showed the most dramatic LDL increases.
The LMHR phenotype is defined by a specific triad:
- LDL cholesterol ≥ 200 mg/dL (5.2 mmol/L)
- HDL cholesterol ≥ 80 mg/dL (2.1 mmol/L)
- Triglycerides ≤ 70 mg/dL (0.8 mmol/L)
By every other metabolic marker — insulin, blood sugar, blood pressure, body composition, inflammatory markers — LMHRs are textbook healthy. Their only “abnormality” is an LDL number that standard risk calculators flag as dangerous.
This isn’t a rare edge case. Research suggests it may affect 5–25% of lean individuals on carbohydrate-restricted diets, depending on how strictly you define the thresholds.
Why Does This Happen?
The leading hypothesis is called the Lipid Energy Model, proposed by Feldman and refined with researchers including Nick Norwitz at Harvard.
Here’s the simplified version:
When you’re lean and keto-adapted, your body has very little stored body fat to draw from relative to its energy needs. To fuel muscles, organs, and daily activity, the liver ramps up production of VLDL particles — the precursors to LDL — to shuttle fat-based fuel through the bloodstream.
Think of it as a supply chain adjustment. A lean person on keto needs more delivery trucks (lipoproteins) to move fat-based fuel around because they have less fat stored locally in adipose tissue. More trucks in circulation means more LDL particles when you measure them.
- BMI is inversely correlated with LDL increase on keto — the leaner you are, the higher LDL tends to go
- Gaining weight reduces LDL in LMHRs — adding body fat decreases the need for lipid trafficking
- The effect is not dependent on saturated fat intake — case reports show the LMHR pattern persists even on low-saturated-fat keto diets
- Triglycerides stay very low — suggesting efficient fat utilisation rather than metabolic dysfunction
But Is It Actually Dangerous?
This is the central question — and the honest answer is: we don’t know for certain yet.
The traditional view in cardiology is straightforward: higher LDL means higher risk. Full stop. By this logic, an LDL of 250 is dangerous regardless of context.
But the LMHR pattern challenges this in several ways:
What the early data shows:
The landmark KETO-CTA trial published in JACC: Advances (2024) used coronary CT angiography — the gold standard for detecting arterial plaque — to examine LMHRs directly. The initial findings showed no significant increase in calcified or non-calcified plaque in participants with the LMHR phenotype compared to controls, though the study was small and short-term.
Case reports have documented individuals maintaining the LMHR pattern for 2+ years with clean coronary CT angiography showing no evidence of plaque accumulation.
What we still need:
- Larger, longer-term studies tracking cardiovascular events (not just plaque)
- Better understanding of whether LMHR-pattern LDL particles behave differently from LDL in metabolically unhealthy individuals
- More data on whether the high HDL and low triglycerides in LMHRs provide a protective counterbalance
Early evidence is encouraging, but it’s not a green light to ignore very high LDL indefinitely. If you’re an LMHR, work with a doctor who understands the phenotype. Consider advanced testing — coronary calcium score, CT angiography, or ApoB measurement — to assess your individual risk rather than relying on LDL alone.
How to Know If You’re an LMHR
If you’re on a keto or carnivore diet and your LDL has gone up significantly, check whether you fit the pattern:
- Are you lean? BMI under 25, or visibly low body fat
- Is your HDL high? Above 80 mg/dL (2.1 mmol/L)
- Are your triglycerides very low? Below 70 mg/dL (0.8 mmol/L)
- Are your other metabolic markers normal? Fasting insulin, blood sugar, blood pressure, inflammatory markers
If you tick all four boxes, you likely fit the LMHR profile. If your LDL is high but your triglycerides are also elevated and HDL is low, that’s a different — and more concerning — pattern.
What Should You Do About It?
1. Don’t Panic — But Don’t Dismiss It
Very high LDL deserves attention regardless of context. The LMHR hypothesis is scientifically plausible and has early supporting data, but it hasn’t been proven safe in large long-term trials.
2. Get Advanced Testing
Standard lipid panels tell you very little. Consider:
- Coronary Artery Calcium (CAC) score — a quick, low-cost CT scan that measures calcified plaque. A score of zero is very reassuring.
- CT Angiography (CTA) — the gold standard for detecting both calcified and soft plaque
- ApoB measurement — counts the actual number of atherogenic particles, giving more resolution than LDL-C alone
- Continuous monitoring — repeat testing every 1–2 years to track trends
3. Optimise What You Can Control
Whether or not LMHR-pattern LDL is benign, you can still reduce overall cardiovascular risk:
- Stay active — regular exercise is one of the strongest protective factors
- Manage stress and sleep — both directly affect cardiovascular health
- Consider omega-3s — EPA/DHA support endothelial function and reduce inflammation
- Stay well hydrated and maintain electrolytes — especially important on keto
- Don’t smoke — amplifies any lipid-related risk
4. Find a Knowledgeable Doctor
Many doctors have never heard of LMHRs and will default to prescribing statins based on LDL alone. Look for a physician who:
- Understands low-carb and ketogenic diets
- Is willing to order advanced cardiovascular testing
- Evaluates risk holistically rather than treating a single number
- The LMHR phenotype is a real, documented pattern where lean keto dieters see very high LDL alongside high HDL and very low triglycerides
- The Lipid Energy Model suggests this reflects increased lipid trafficking for fuel, not metabolic dysfunction
- Early imaging studies show no excess plaque in LMHRs, but long-term data is limited
- Don’t rely on LDL alone — get advanced testing (CAC score, CTA, ApoB) to assess actual cardiovascular risk
- Work with a doctor who understands the phenotype and evaluates the full metabolic picture
The Bottom Line
The LMHR effect highlights something important: context matters in medicine. An LDL of 250 in someone who is overweight, insulin resistant, and inflamed tells a very different story than the same number in a lean, metabolically healthy person with sky-high HDL and rock-bottom triglycerides.
The science is still catching up to this distinction. Until we have definitive long-term outcome data, the smartest approach is to stay informed, get advanced testing, and work with a doctor who sees you as a whole person — not just a lipid panel.
Your six-pack and your cholesterol number can coexist. You just need to understand why.
Sources
- Case Report: Hypercholesterolemia 'Lean Mass Hyper-Responder' Phenotype Presents in the Context of a Low Saturated Fat Carbohydrate-Restricted Diet — Frontiers in Endocrinology (2022-03-09)
- Carbohydrate Restriction-Induced Elevations in LDL-Cholesterol and Atherosclerosis: The KETO Trial — JACC: Advances (2024-09-01)
- The impact of dietary fat type on lipid profiles in lean mass hyper-responder phenotype — PMC / Lipids in Health and Disease (2024-02-01)